Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Telix (TLX) To Contact Him Directly To Discuss Their Options If you purchased or acquired...
-
According to the lawsuit, Telix overstated prostate cancer drug progress and supply-chain quality, making its public statements misleading.
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Telix To Contact Him Directly To Discuss Their Options If you purchased or...
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Telix To Contact Him Directly To Discuss Their Options If you purchased or...
-
Telix Pharmaceuticals Limited investors that lost money are encouraged to contact BG&G before the January 9, 2026 lead plaintiff deadline.
-
Telix Pharmaceuticals Limited investors that lost money are encouraged to contact BG&G before the January 9, 2026 lead plaintiff deadline.
-
The lawsuit alleges Telix overstated progress on its prostate cancer candidates and supply-chain strength, making its public statements misleading.
-
Telix Pharmaceuticals Limited investors that lost money are encouraged to contact BG&G before the January 9, 2026 lead plaintiff deadline.
-
Telix Pharmaceuticals Limited investors that lost money are encouraged to contact BG&G before the January 9, 2026 lead plaintiff deadline.
-
Telix Pharmaceuticals Limited investors that lost money are encouraged to contact BG&G before the January 9, 2026 lead plaintiff deadline.